Immunome Inc. (IMNM)
NASDAQ · Healthcare
Immunome Inc. Total Liabilities 2023–2025
Immunome Inc. annual/quarterly total liabilities history from 2023 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Immunome Inc. total liabilities for the quarter ending December 31, 2025 were 48.8M, a 17.32% decrease year-over-year.
- Immunome Inc. total liabilities for 2025 were 48.8M, a 17.32% decrease from 2024.
- Immunome Inc. total liabilities for 2024 were 59.1M, a 106.14% increase from 2023.
- Immunome Inc. total liabilities for 2023 were 28.7M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Immunome Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $49 |
| 2024 | $59 |
| 2023 | $29 |
| Immunome Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $49 |
| 2024-12-31 | $59 |
| 2023-12-31 | $29 |
Immunome Inc. Total Liabilities — FAQ
Immunome Inc. (IMNM) total liabilities over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IMNM's total liabilities history?
The chart and table above show Immunome Inc.'s total liabilities by year and by quarter, including the growth rate.